Progression to GMP (Good Manufacturing Practice) validation, the standard required for routine use in commercial biopharmaceutical manufacturing, demonstrates the regulatory readiness of Oxford ...
The launch follows the industry’s first GLP-validated (Good Laboratory Practice) AVA detection test using Oxford Nanopore sequencing in August 2025. Progression to GMP (Good Manufacturing Practice) ...
First-in-class solution consolidates multiple assays into a single test, enabling broader viral detection, faster time-to-result and more confident decision-making in regulated biopharmaceutical ...
ViruSure, an Asahi Kasei company and global leader in pathogen safety testing for biopharmaceuticals, today announced the launch of the world’s first GMP-validated adventitious viral agent (AVA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results